{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T17:06:36Z","timestamp":1775063196305,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.nucmedbio.2010.08.008","type":"journal-article","created":{"date-parts":[[2010,10,28]],"date-time":"2010-10-28T08:17:04Z","timestamp":1288253824000},"page":"159-163","source":"Crossref","is-referenced-by-count":9,"title":["Unexpected side products in the conjugation of an amine-derivatized morpholino oligomer with p-isothiocyanate benzyl DTPA and their removal"],"prefix":"10.1016","volume":"38","author":[{"given":"Guozheng","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuping","family":"Dou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minmin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dengfeng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dale","family":"Greiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Rusckowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald J.","family":"Hnatowich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2010.08.008_bb0005","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.bmcl.2003.12.074","article-title":"Biodistribution of phosphodiester and phosphorothioate siRNA","volume":"14","author":"Braasch","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.nucmedbio.2010.08.008_bb0010","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1124\/dmd.106.009555","article-title":"Intravenously administered short interfering RNA accumulates in the kidney and selectively suppresses gene function in renal proximal tubules","volume":"34","author":"van de Water","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.nucmedbio.2010.08.008_bb0015","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1021\/bc800408g","article-title":"In vivo SPECT and real-time gamma camera imaging of biodistribution and pharmacokinetics of siRNA delivery using an optimized radiolabeling and purification procedure","volume":"20","author":"Merkel","year":"2009","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nucmedbio.2010.08.008_bb0020","doi-asserted-by":"crossref","first-page":"15549","DOI":"10.1073\/pnas.0707461104","article-title":"Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging","volume":"104","author":"Bartlett","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.nucmedbio.2010.08.008_bb0025","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/bit.21668","article-title":"Impact of tumor-specific targeting and dosing schedule on tumor growth inhibition after intravenous administration of siRNA-containing nanoparticles","volume":"99","author":"Bartlett","year":"2008","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.nucmedbio.2010.08.008_bb0030","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.nucmedbio.2007.02.006","article-title":"Radiolabeling small RNA with technetium-99m for visualizing cellular delivery and mouse biodistribution","volume":"34","author":"Liu","year":"2007","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2010.08.008_bb0035","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0167-4781(99)00140-2","article-title":"A review of the issues in the pharmacokinetics and toxicology of phosphorothioate antisense oligonucleotides","volume":"1489","author":"Levin","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.nucmedbio.2010.08.008_bb0040","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1093\/nar\/25.16.3290","article-title":"In vivo fate of phosphorothioate antisense oligodeoxynucleotides: predominant uptake by scavenger receptors on endothelial liver cells","volume":"25","author":"Bijsterbosch","year":"1997","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.nucmedbio.2010.08.008_bb0045","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejps.2005.04.017","article-title":"Biodistribution of 68Ga-labelled phosphodiester, phosphorothioate, and 2-O-methyl phosphodiester oligonucleotides in normal rats","volume":"26","author":"Lendvai","year":"2005","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.nucmedbio.2010.08.008_bb0050","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0969-8051(02)00389-X","article-title":"Radiolabeling morpholinos with 90Y, 111In, 188Re and 99mTc","volume":"30","author":"Liu","year":"2003","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2010.08.008_bb0055","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1097\/00006231-200411000-00008","article-title":"Initial observations of 99mTc-labeled locked nucleic acids for antisense targeting","volume":"25","author":"Zhang","year":"2004","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.nucmedbio.2010.08.008_bb0060","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.nucmedbio.2005.10.009","article-title":"Construction of a novel chimera consisting of a chelator-containing Tat peptide conjugated to a morpholino antisense oligomer for technetium-99m labeling and accelerating cellular kinetics","volume":"33","author":"Zhang","year":"2006","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2010.08.008_bb0065","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1021\/bc0100307","article-title":"Pretargeting with amplification using polymeric peptide nucleic acid","volume":"12","author":"Wang","year":"2001","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nucmedbio.2010.08.008_bb0070","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1021\/bc034084n","article-title":"Synthesis of radiometal-labeled and fluorescent cell-permeating peptide\u2013PNA conjugates for targeting the bcl-2 proto-oncogene","volume":"14","author":"Gallazzi","year":"2003","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nucmedbio.2010.08.008_bb0075","doi-asserted-by":"crossref","first-page":"430","DOI":"10.2967\/jnumed.107.045138","article-title":"Molecular imaging of bcl-2 expression in small lymphocytic lymphoma using 111In-labeled PNA\u2013peptide conjugates","volume":"49","author":"Jia","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2010.08.008_bb0080","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1021\/bc00019a013","article-title":"Specific recognition of antibody\u2013oligonucleotide conjugates by radiolabeled antisense nucleotides: a novel approach for two-step radioimmunotherapy of cancer","volume":"4","author":"Kuijpers","year":"1993","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nucmedbio.2010.08.008_bb0085","first-page":"3479","article-title":"In vitro evaluation of DNA\u2013DNA hybridization as a two-step approach in radioimmunotherapy of cancer","volume":"54","author":"Bos","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2010.08.008_bb0090","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1002\/(SICI)1097-0142(19971215)80:12+<2699::AID-CNCR48>3.0.CO;2-4","article-title":"Pretargeting using peptide nucleic acid","volume":"80","author":"Rusckowski","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.nucmedbio.2010.08.008_bb0095","first-page":"384","article-title":"Tumor pretargeting in mice using 99mTc-labeled morpholino, a DNA analog","volume":"43","author":"Liu","year":"2002","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2010.08.008_bb0100","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1021\/bc0255384","article-title":"Improving the labeling of S-acetyl NHS-MAG3-conjugated morpholino oligomers","volume":"13","author":"Liu","year":"2002","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nucmedbio.2010.08.008_bb0105","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.apradiso.2006.04.005","article-title":"Radiolabeling of MAG3-morpholino oligomers with 188Re at high labeling efficiency and specific radioactivity for tumor pretargeting","volume":"64","author":"Liu","year":"2006","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2010.08.008_bb0110","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/nprot.2006.262","article-title":"Methods for MAG3 conjugation and 99mTc radiolabeling of biomolecules","volume":"1","author":"Wang","year":"2006","journal-title":"Nat Protoc"},{"key":"10.1016\/j.nucmedbio.2010.08.008_bb0115","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s11307-009-0209-0","article-title":"Replacing 99mTc with 111In improves MORF\/cMORF pretargeting by reducing intestinal accumulation","volume":"11","author":"Liu","year":"2009","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.nucmedbio.2010.08.008_bb0120","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.apradiso.2010.03.002","article-title":"Preparation of 111In-DTPA morpholino oligomer for low abdominal accumulation","volume":"68","author":"Liu","year":"2010","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2010.08.008_bb0125","doi-asserted-by":"crossref","first-page":"4958","DOI":"10.1158\/1078-0432.CCR-06-0844","article-title":"Successful radiotherapy of tumor in pretargeted mice by 188Re-radiolabeled phosphorodiamidate morpholino oligomer, a synthetic DNA analogue","volume":"12","author":"Liu","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nucmedbio.2010.08.008_bb0130","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1021\/bc000070v","article-title":"Bifunctional chelators for therapeutic lanthanide radiopharmaceuticals","volume":"12","author":"Liu","year":"2001","journal-title":"Bioconjugate Chem"},{"key":"10.1016\/j.nucmedbio.2010.08.008_bb0135","first-page":"166","article-title":"Bifunctional chelates for metal nuclides","volume":"52","author":"Brechbiel","year":"2008","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2010.08.008_bb0140","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.addr.2008.04.006","article-title":"Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides","volume":"60","author":"Liu","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nucmedbio.2010.08.008_bb0145","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1021\/ic00236a024","article-title":"Synthesis of 1-(p-isothiocyanatobenzyl) derivatives of DTPA and EDTA. Antibody labeling and tumor-imaging studies","volume":"25","author":"Brechbiel","year":"1986","journal-title":"Inorg Chem"},{"key":"10.1016\/j.nucmedbio.2010.08.008_bb0150","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00259-003-1393-9","article-title":"Pretargeting in tumored mice with radiolabeled morpholino oligomer showing low kidney uptake","volume":"31","author":"Liu","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2010.08.008_bb0155","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1021\/jo01054a076","article-title":"Reaction of anthranilonitrile and N-methylanthranilonitrile with phenyl isocyanate and phenyl isothiocyanate","volume":"27","author":"Taylor","year":"1962","journal-title":"J Org Chem"},{"key":"10.1016\/j.nucmedbio.2010.08.008_bb0160","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1021\/jo00901a031","article-title":"2-Amino-2-thiazoline. VIII. A nonregioselective reaction of 2-amino-2-thiazoline with benzoyl isothiocyanate to give a thermally unstable thiourea and a thiazolotriazine","volume":"40","author":"Klayman","year":"1975","journal-title":"J Org Chem"},{"key":"10.1016\/j.nucmedbio.2010.08.008_bb0165","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1021\/jo962376u","article-title":"Solution-phase synthesis of a combinatorial thiohydantoin library","volume":"62","author":"Sim","year":"1997","journal-title":"J Org Chem"},{"key":"10.1016\/j.nucmedbio.2010.08.008_bb0170","doi-asserted-by":"crossref","first-page":"10194","DOI":"10.1021\/jo0517702","article-title":"Single-step syntheses of 2-amino-7-chlorothiazolo[5,4-d]pyrimidines: intermediates for bivalent thiazolopyrimidines.","volume":"70","author":"Liu","year":"2005","journal-title":"J Org Chem"},{"key":"10.1016\/j.nucmedbio.2010.08.008_bb0175","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1021\/jo01075a603","article-title":"Dimer of 2-pyridyl isothiocyanate","volume":"25","author":"Howard","year":"1960","journal-title":"J Organ Chem"},{"key":"10.1016\/j.nucmedbio.2010.08.008_bb0180","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1021\/jo00360a052","article-title":"Reactions of 4,5-dihydro-2-thiazolamin with phenyl isothiocyanate and phenyl isocyanate: a reinvestigation","volume":"51","author":"Rasmussen","year":"1986","journal-title":"J Org Chem"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805110004154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805110004154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T21:51:25Z","timestamp":1572990685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805110004154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0969805110004154"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2010.08.008","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}